AI tool predicts diseases: ‘The risk is that we might interpret it the wrong way.’

Recently, INDICATE co-lead Michel van Genderen shared his expertise on the Dutch national news program NOS Nieuwsuur, discussing the risks associated with AI tools such as Delphi-2M, which predicts the likelihood of developing diseases.

How much risk does someone have of developing a disease like cancer? Or of having a heart attack? The Delphi-2M system can predict that. But does it really help us? Or does it also come with risks?

“When I read about it, I thought: yet another prediction model. Research shows that only two percent of all AI innovations are actually used in healthcare. Innovations often don’t fit well with real-world practice,” says Michel van Genderen, internist-intensivist and co-founder of the AI ethics lab REAiHL, a collaboration between Erasmus MC and TU Delft.

Van Genderen and his colleagues advise the World Health Organization (WHO) on the use of AI in healthcare: “Embracing AI in healthcare will go wrong if there are no moral ground rules. It must be safe and ethical.”

Read the full article here (in Dutch) or watch the news item here (in Dutch). The item starts at 30:30 minutes.

Source: NOS Nieuwsuur